The FDA has suggested an Indian API maker hire a consultant that understands FDA regulations after finding the company didn’t have a grasp of some basic requirements, including how to make sure the ...
In its third exit from an Indian portfolio company within a month, Asia focused hedge fund Steadview Capital has sold more stake in a publicly listed active pharmaceutical ingredients (API) maker.
An arm of the private equity firm TPG will invest $30 million in Solara Active Pharma, a maker of active pharmaceutical ingredients (APIs). Solara has five manufacturing sites and two research centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results